Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/28/2012CN101296702B Compositions and methods for the diagnosis and therapy of BCL2-associated cancers
11/28/2012CN101279955B N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
11/28/2012CN101268050B Isotopically substituted pantoprazole
11/28/2012CN101260114B Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation
11/28/2012CN101258130B Isoquinolines as igf-1r inhibitors
11/28/2012CN101123964B G-protein coupled receptor(GPR116) agonists and use thereof for treating obesity and diabetes
11/28/2012CN101107225B 12-aryl prostaglandin analogs
11/28/2012CN101072588B Liposomes with improved drug retention for treatment of cancer
11/28/2012CN101010088B Compositions and methods of use for treatment of mammalian diseases
11/27/2012USRE43833 Thiazolidin-4-one derivatives
11/27/2012US8318952 Substituted indole derivatives for the treatment of respiratory diseases
11/27/2012US8318951 Stem cell differentiating agents and uses therefor
11/27/2012US8318949 Organic compounds
11/27/2012US8318945 Metalloprotein inhibitors
11/27/2012US8318941 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
11/27/2012US8318940 Naphthyridin-2 (1 H)-one compounds useful as antibacterials
11/27/2012US8318939 Kinase inhibitors
11/27/2012US8318935 Organic compounds 75074
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318816 Enhanced transport using membrane disruptive agents
11/27/2012US8318815 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/27/2012US8318814 Glyceryl ether compounds and their use
11/27/2012US8318813 Method of treating binge eating disorder
11/27/2012US8318812 Therapeutic agents for the treatment of lymphoid malignancies
11/27/2012US8318811 Method for treating an inflammatory bowel disease using 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol or a salt thereof
11/27/2012US8318810 Methods for treating neural cell swelling
11/27/2012US8318809 Compositions and methods for treating jellyfish stings
11/27/2012US8318808 Zn2+chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
11/27/2012US8318807 Pterostilbene cocrystals
11/27/2012US8318806 Deodorizing composition and method of forming thereof
11/27/2012US8318805 Modulation of nitric oxide synthases by betaines
11/27/2012US8318804 Antiviral activity of cyclopentene nitro-ester and derivatives
11/27/2012US8318802 Epoprostenol formulation and method of making thereof
11/27/2012US8318800 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents
11/27/2012US8318799 Therapeutic agent for substance dependence
11/27/2012US8318798 Therapeutic agent for neurodegenerative disease
11/27/2012US8318797 Composition and methods for the protection of hair from treated pool water
11/27/2012US8318796 Heterocyclic compounds and thrombopoietin receptor activators
11/27/2012US8318795 Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
11/27/2012US8318794 Method of use of porphyrins in preparing a medicament for sonodynamic therapy and a method of sonodynamic therapy using porphyrins
11/27/2012US8318793 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
11/27/2012US8318792 Therapeutic agent for amyotrophic lateral sclerosis
11/27/2012US8318791 Substituted imidazole derivatives
11/27/2012US8318790 Heat Shock Protein 90 (HSP90); treating cancer, inflammatory disorders, angiogenesis inhibition, infections; 3-substituted-4-fused(hetero)aryl-5-phenyl-4H-1,2,4-triazoles
11/27/2012US8318789 Co-crystals of propiconazole
11/27/2012US8318788 Layered pharmaceutical formulations
11/27/2012US8318787 Prodrugs of (3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-C]oxazol-7A-yl)methanol and derivatives thereof
11/27/2012US8318786 Plant pathogen resistance
11/27/2012US8318785 Pharmaceutical compounds
11/27/2012US8318784 Tricyclic compound and pharmaceutical use thereof
11/27/2012US8318783 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
11/27/2012US8318782 Mitotic kinesin inhibitor
11/27/2012US8318781 G-protein-conjugated receptor agonist
11/27/2012US8318780 Methods of administering pirfenidone therapy
11/27/2012US8318779 Lysine related derivatives as HIV aspartyl protease inhibitors
11/27/2012US8318778 Urea glucokinase activators
11/27/2012US8318775 N-(heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
11/27/2012US8318774 N-(3-((thiazol-2-yl)amino)propyl)-3-phenylpropiolamide, 4-(thiazol-2-yl-amino)-1-(3-phenyl-propiolyl)piperidine, for example; for preventing or treating a disorder or disease that is mediated at least in part by mGluR26 receptors, such as pain, migraines, depression, neurodegenerative diseases
11/27/2012US8318773 Isoindoline compounds and methods of their use
11/27/2012US8318772 Amine compounds and medical uses thereof
11/27/2012US8318771 Method of treatment of nephrogenic diabetes insipidus
11/27/2012US8318770 Tetrahydroquinoline indole derivatives and uses thereof
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318768 Bronchodilating alpha, beta-unsaturated isoquinoline amides
11/27/2012US8318767 Substituted imidazoles as bombesin receptor subtype-3 modulators
11/27/2012US8318766 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/27/2012US8318764 Macrocyclic inhibitors of JAK
11/27/2012US8318763 Rifamycin derivatives
11/27/2012US8318762 Pyrazolospiroketone acetyl-CoA carboxylase inhibitors
11/27/2012US8318761 Substituted arylsulfonamides as antiviral agents
11/27/2012US8318760 Type 2 diabetes, atherosclerosis; compounds are N-(2-carboxyethyl)benzamides or N-tetrazolyl derivatives of benzamides; glucagon antagonists
11/27/2012US8318759 Pyrrolidine derivatives as NK3 receptor antagonists
11/27/2012US8318757 Substituted isoxazoline compound and pest control agent
11/27/2012US8318756 Dihydropyrimidine dehydrogenase (DPD) inhibitors; 5-fluorouracil; anticancer
11/27/2012US8318755 Inhibitors of SYK and JAK protein kinases
11/27/2012US8318754 Pyrimidinecarboxamide derivatives
11/27/2012US8318753 (-)-5-(3-Chlorophenyl)- alpha -(4-chlorophenyl)- alpha -(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts; anticancer agent
11/27/2012US8318752 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
11/27/2012US8318751 Pyrimidinone derivatives and methods of use thereof
11/27/2012US8318750 Organic compounds
11/27/2012US8318749 Quinazoline derivatives as NK3 receptor antagonists
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318747 2,5-disubstituted arylsulfonamide CCR3 antagonists
11/27/2012US8318746 Nitrogen-containing five-membered heterocyclic compound
11/27/2012US8318745 Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318743 Medicament for the enhancement of cognitive function and neuroprotection
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318741 Therapeutic compositions and methods
11/27/2012US8318740 Compounds for protein kinase inhibition
11/27/2012US8318739 Remedy for corneal diseases
11/27/2012US8318738 Reverse-turn mimetics and method relating thereto
11/27/2012US8318737 Compounds and compositions for treating cancer
11/27/2012US8318736 HIV inhibiting 5,6-substituted pyrimidines
11/27/2012US8318735 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
11/27/2012US8318733 Modulators of ATP-binding cassette transporters
11/27/2012US8318732 Compounds having antiviral properties
11/27/2012US8318731 Pyrrolopyrimidines
11/27/2012US8318730 Fused hetrocyclic compounds
11/27/2012US8318729 Phenylacetic acid compound
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 7860